dronabinol has been researched along with Recrudescence in 13 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 2 (15.38) | 18.2507 |
2000's | 4 (30.77) | 29.6817 |
2010's | 5 (38.46) | 24.3611 |
2020's | 2 (15.38) | 2.80 |
Authors | Studies |
---|---|
Bedi, G; Cooper, ZD; Foltin, RW; Haney, M; Herrmann, ES; Kingsley, PJ; Marnett, LJ; Patel, S; Reed, SC | 1 |
Berrendero, F; Flores, Á; Maldonado, R | 1 |
Bergman, J; Goldberg, SR; Justinova, Z; Le Foll, B; Makriyannis, A; Redhi, GH; Schindler, CW; Vemuri, K | 1 |
Cadet, JL; Chiang, CN; Darwin, WD; Gorelick, DA; Gullberg, RG; Huestis, MA; Pope, HG; Schwilke, EW | 1 |
Arnold, JC; Chesworth, R; Huang, XF; Karl, T; Long, LE; McGregor, IS | 1 |
Evins, AE; Green, AI; Kane, JM; Murray, RM | 1 |
Agosti, V; Bisaga, A; Brooks, DJ; Carpenter, KM; Levin, FR; Mariani, J; Nunes, EV; Pavlicova, M; Sullivan, MA | 1 |
Berger, T; Brenneis, C; Haydn, T; Müller, J; Poewe, W; Schelosky, LD; Wissel, J | 1 |
Burkard, I; Shayanfar, N | 1 |
Bowers, MB; Druss, B; Imirowicz, R; Mazure, CM | 1 |
Calcedo-Ordoñez, A; Martinez-Arevalo, MJ; Varo-Prieto, JR | 1 |
Achiron, A; Biegon, A; Lavie, V; Margalit, R; Miron, S | 1 |
Crombag, H; De Vries, TJ; Dieben, J; Homberg, JR; Schoffelmeer, AN; Schuurman, K; Shaham, Y; Vanderschuren, LJ | 1 |
3 trial(s) available for dronabinol and Recrudescence
Article | Year |
---|---|
Impact of cyclooxygenase-2 inhibition on cannabis withdrawal and circulating endocannabinoids in daily cannabis smokers.
Topics: Cannabinoid Receptor Agonists; Cannabis; Celecoxib; Cross-Over Studies; Cyclooxygenase 2; Dronabinol; Endocannabinoids; Humans; Marijuana Abuse; Recurrence; Smokers; Substance Withdrawal Syndrome | 2022 |
A randomized double-blind, placebo-controlled trial of venlafaxine-extended release for co-occurring cannabis dependence and depressive disorders.
Topics: Adult; Antidepressive Agents, Second-Generation; Cognitive Behavioral Therapy; Combined Modality Therapy; Cyclohexanols; Delayed-Action Preparations; Depressive Disorder, Major; Double-Blind Method; Dronabinol; Female; Humans; Male; Marijuana Abuse; Medication Adherence; Recurrence; Selective Serotonin Reuptake Inhibitors; Treatment Failure; Venlafaxine Hydrochloride | 2013 |
Low dose treatment with the synthetic cannabinoid Nabilone significantly reduces spasticity-related pain : a double-blind placebo-controlled cross-over trial.
Topics: Activities of Daily Living; Adolescent; Adult; Cross-Over Studies; Double-Blind Method; Dronabinol; Female; Humans; Male; Middle Aged; Motor Neuron Disease; Muscle Spasticity; Pain; Pain Measurement; Recurrence | 2006 |
10 other study(ies) available for dronabinol and Recrudescence
Article | Year |
---|---|
THC exposure during adolescence does not modify nicotine reinforcing effects and relapse in adult male mice.
Topics: Age Factors; Animals; Conditioning, Operant; Cues; Dose-Response Relationship, Drug; Dronabinol; Hallucinogens; Male; Mice; Mice, Inbred C57BL; Nicotine; Recurrence; Reinforcement, Psychology; Self Administration | 2020 |
Blockade of Nicotine and Cannabinoid Reinforcement and Relapse by a Cannabinoid CB1-Receptor Neutral Antagonist AM4113 and Inverse Agonist Rimonabant in Squirrel Monkeys.
Topics: Animals; Conditioning, Operant; Cues; Dronabinol; Drug-Seeking Behavior; Male; Marijuana Abuse; Nicotine; Piperidines; Pyrazoles; Receptor, Cannabinoid, CB1; Recurrence; Reinforcement, Psychology; Rimonabant; Saimiri; Self Administration; Tobacco Use Disorder | 2016 |
Differentiating new cannabis use from residual urinary cannabinoid excretion in chronic, daily cannabis users.
Topics: Adult; Algorithms; Chronic Disease; Creatinine; Diagnosis, Differential; Dronabinol; Drug Residues; Female; Gas Chromatography-Mass Spectrometry; Humans; Male; Marijuana Abuse; Models, Biological; Nonlinear Dynamics; Predictive Value of Tests; Psychotropic Drugs; Recurrence; Substance Abuse Detection; Time Factors; Young Adult | 2011 |
Transmembrane domain Nrg1 mutant mice show altered susceptibility to the neurobehavioural actions of repeated THC exposure in adolescence.
Topics: Aging; Animals; Dronabinol; Exploratory Behavior; Male; Membrane Proteins; Mice; Mice, Transgenic; Motor Activity; Mutation; Neuregulin-1; Recurrence; Reflex, Startle; Social Behavior | 2013 |
The effect of marijuana use on the risk for schizophrenia.
Topics: Adolescent; Adult; Age of Onset; Alcohol Drinking; Cannabis; Causality; Child; Child, Preschool; Comorbidity; Dose-Response Relationship, Drug; Dronabinol; Female; Gene-Environment Interaction; Genetic Predisposition to Disease; Humans; Infant; Infant, Newborn; Marijuana Abuse; Marijuana Smoking; Pregnancy; Psychoses, Substance-Induced; Recurrence; Risk; Schizophrenia; Schizophrenic Psychology; Social Facilitation; Telecommunications; United States; Young Adult | 2012 |
[CME laboratory 1/solution. Chronic cannabis use].
Topics: Adolescent; Creatinine; Dronabinol; Humans; Male; Marijuana Abuse; Metabolic Clearance Rate; Patient Compliance; Recurrence; Substance Abuse Detection | 2006 |
Autonomous psychosis following psychotogenic substance abuse.
Topics: Cocaine; Dronabinol; Female; Humans; Lysergic Acid Diethylamide; Male; Middle Aged; Psychoses, Substance-Induced; Psychotropic Drugs; Recurrence; Risk Factors; Schizophrenia | 1995 |
Cannabis consumption as a prognostic factor in schizophrenia.
Topics: Adolescent; Adult; Comorbidity; Dronabinol; Female; Follow-Up Studies; Humans; Male; Marijuana Abuse; Patient Compliance; Recurrence; Schizophrenia; Schizophrenic Psychology; Stress, Psychological; Treatment Outcome | 1994 |
Dexanabinol (HU-211) effect on experimental autoimmune encephalomyelitis: implications for the treatment of acute relapses of multiple sclerosis.
Topics: Acute Disease; Animals; Brain; Dose-Response Relationship, Drug; Dronabinol; Encephalomyelitis, Autoimmune, Experimental; Female; Injections, Intraperitoneal; Injections, Intravenous; Multiple Sclerosis; Neuroprotective Agents; Rats; Rats, Inbred Lew; Recurrence; Spinal Cord; Time Factors; Treatment Outcome | 2000 |
A cannabinoid mechanism in relapse to cocaine seeking.
Topics: Animals; Behavior, Animal; Cannabinoid Receptor Modulators; Cannabinoids; Cocaine; Cocaine-Related Disorders; Disease Models, Animal; Dronabinol; Humans; Piperidines; Pyrazoles; Rats; Rats, Long-Evans; Rats, Wistar; Receptors, Cannabinoid; Receptors, Drug; Recurrence; Rimonabant | 2001 |